300511 雪榕生物
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.336-11.405-16.833-15.83412.264
总资产报酬率 ROA (%)0.109-4.336-6.831-6.5725.493
投入资产回报率 ROIC (%)0.127-5.035-7.788-7.5366.327

边际利润分析
销售毛利率 (%)12.9778.38410.7045.26321.841
营业利润率 (%)1.759-7.422-16.166-15.8429.849
息税前利润/营业总收入 (%)6.963-4.215-12.923-12.55712.216
净利润/营业总收入 (%)1.772-7.498-16.985-16.0779.455

收益指标分析
经营活动净收益/利润总额(%)17.78771.215-1.44645.833104.611
价值变动净收益/利润总额(%)0.0001.381-2.331-0.3001.957
营业外收支净额/利润总额(%)0.7550.8901.4262.776-5.807

偿债能力分析
流动比率 (X)0.6560.3630.9190.5450.887
速动比率 (X)0.3930.1530.5770.3060.611
资产负债率 (%)71.24168.87660.07361.87855.891
带息债务/全部投入资本 (%)61.92656.62647.23451.56946.612
股东权益/带息债务 (%)56.91071.595101.52286.616107.981
股东权益/负债合计 (%)43.42449.04271.26462.26079.361
利息保障倍数 (X)1.341-1.287-3.717-3.3594.201

营运能力分析
应收账款周转天数 (天)4.8154.3864.4904.5943.375
存货周转天数 (天)78.93867.87271.87370.62174.660